Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...
Pulse Biosciences (Nasdaq:PLSE) today announced the enrollment of the first patient in its NANOCLAMP AF study for treating ...
A pioneering procedure is showcasing the future of medicine. UC Health performed the region's first fully robotic heart procedure.
According to a new study, a high-voltage pulsed field ablation catheter effectively created transmural ventricular lesions, ...
TipRanks on MSN
Shanghai Bio-heart Achieves Milestone with First Iberis® RDN System Procedure in Switzerland
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( ($HK:2185) ) just unveiled an update. Shanghai Bio-heart Biological Technology Co., ...
What they’re getting out of those AI programs is not necessarily a real, scientific recommendation with an actual publication ...
The YorLabs system enables single-operator control and provides high-resolution, real-time imaging for a wide range of intracardiac procedures. Its compact, wireless system integrates seamlessly into ...
Dr. Greg Hundley: Yes, Peder, let's go. Dr. Peder Myhre: ...
Q3 2025 Earnings Call Transcript October 23, 2025 Roper Technologies, Inc. beats earnings expectations. Reported EPS is $5.14 ...
Key points A 68-year-old woman from rural Ontario arrived at her local emergency department with worsening palpitations. Her medical history included breast cancer treated with surgical resection and ...
For patients suffering from severe and uncontrollable heart rhythm problems, a new study brings promising news. Radiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback